Cargando…

113: SPECIFIC TARGETING OF HER2-POSITIVE BREAST CANCER CELL LINE (SK-BR3) USING IDARUBICIN-LOADED ANTI-HER2 IMMUNOLIPOSOME

Cytotoxic chemotherapy drugs which are used for treating malignant cells cannot distinguish between normal and cancerous cells. This would lead to adverse side effects. Moreover, drug resistance is another major problem of the classical chemotherapy during the treatment period. Recently, various the...

Descripción completa

Detalles Bibliográficos
Autores principales: Pourshohod, Aminollah, Zeinali, Majid, Afrakhte, Moslem, Jamalan, Mostafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759544/
http://dx.doi.org/10.1136/bmjopen-2016-015415.113

Ejemplares similares